ArticlePloS one2017
Reproducibility, reliability and validity of population-based administrative health data for the assessment of cancer non-related comorbidities.
Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
55 citing papers in PubMed, 1 synthesis or guideline pooled it, 95 citations in OpenAlex.
- Effectiveness of surgical interventions in patients with severe pressure ulcers: the SIPS mixed-methods exploratory study.Health technology assessment (Winchester, England) · 2025Pooled it
- Socioeconomic inequality in treatment of acute myeloid leukaemia (AML) in England, 2015-2022: A population-based study.British journal of haematology · 2026Article
- Case-mix-adjusted benchmarking of long-term breast cancer-specific mortality: Insights from a nationwide Swedish registry.Breast (Edinburgh, Scotland) · 2026Article
- Socioeconomic Status and Survival in Sarcomas of the Breast: Nationwide Cohort Study.Annals of surgical oncology · 2026Article
- Male sex adversely impacts survival and myeloid malignancy risk in MGUS: a real-world population-based study.Haematologica · 2026Article
- Colorectal cancer outcomes show relationships with the type and extent of vascular complications in individuals with diabetes: A population-based study.Diabetic medicine : a journal of the British Diabetic Association · 2026Article
- Prediagnostic primary care consultations and imaging in emergency-diagnosed versus referred patients with lung cancer: a population-based linked data study.The British journal of general practice : the journal of the Royal College of General Practitioners · 2026Article
- A comprehensive nationwide registry study of noncommunicable disease comorbidities and death in cancer patients in Norway-the NCDNOR project.Scientific reports · 2026Article
- Minimally invasive surgical resection reduces one-year mortality, especially in high-risk colon cancer patients: an emulated trial.EClinicalMedicine · 2026Article
- Cancer stage at diagnosis by duration of pre-existing chronic analgesic use and anxiety or depression.Nature communications · 2025Article
- Doubling in median survival in patients diagnosed with multiple myeloma 2005-2019; a real-world study from the UK's Haematological Malignancy Research Network.Haematologica · 2025Article
- Socio-economic inequalities in second primary cancer incidence: A competing risks analysis of women with breast cancer in England between 2000 and 2018.International journal of cancer · 2025Article
- Prevalence and outcomes of patients taking oral corticosteroids for over 1 month undergoing major surgery in England 2010-2020.Anaesthesia · 2025Article
- Discriminative Ability of the Charlson Comorbidity Index for Long-Term Mortality in a General Population: Nationwide, Population-Based Study of 10 Million Adults in Sweden.Clinical epidemiology · 2025Article
- Comparison of common multiple imputation approaches: An application of logistic regression with an interaction.Research methods in medicine & health sciences · 2025Article
- The spectrum of co-existing disease in children with established kidney failure using registry and linked electronic health record data.Pediatric nephrology (Berlin, Germany) · 2024Article
- Postoperative complications after breast cancer surgery and effect on recurrence and survival: population-based cohort study.BJS open · 2024Article
- Impact of observability period on the classification of COPD diagnosis timing among Medicare beneficiaries with lung cancer.PLOS digital health · 2024Article
- COPD With Lung Cancer Among Older United States Adults: Prevalence, Diagnostic Timeliness, and Association With Earlier Stage Tumors.Chronic obstructive pulmonary diseases (Miami, Fla.) · 2024Article
- Instrumental activities of daily living in older patients with metastatic prostate cancer: results from the meet-URO network ADHERE prospective study.Scientific reports · 2024Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
Abstract
backgroundPatients with comorbidities do not receive optimal treatment for their cancer, leading to lower cancer survival. Information on individual comorbidities is not straightforward to derive from population-based administrative health datasets. We described the development of a reproducible algorithm to extract the individual Charlson index comorbidities from such data. We illustrated the algorithm with 1,789 laryngeal cancer patients diagnosed in England in 2013. We aimed to clearly set out and advocate the time-related assumptions specified in the algorithm by providing empirical evidence for them.
methodsComorbidities were assessed from hospital records in the ten years preceding cancer diagnosis and internal reliability of the hospital records was checked. Data were right-truncated 6 or 12 months prior to cancer diagnosis to avoid inclusion of potentially cancer-related comorbidities. We tested for collider bias using Cox regression.
resultsOur administrative data showed weak to moderate internal reliability to identify comorbidities (ICC ranging between 0.1 and 0.6) but a notably high external validity (86.3%). We showed a reverse protective effect of non-cancer related Chronic Obstructive Pulmonary Disease (COPD) when the effect is split into cancer and non-cancer related COPD (Age-adjusted HR: 0.95, 95% CI:0.7-1.28 for non-cancer related comorbidities). Furthermore, we showed that a window of 6 years before diagnosis is an optimal period for the assessment of comorbidities.
conclusionTo formulate a robust approach for assessing common comorbidities, it is important that assumptions made are explicitly stated and empirically proven. We provide a transparent and consistent approach useful to researchers looking to assess comorbidities for cancer patients using administrative health data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.